CUTANEOUS T-CELL LYMPHOMA STAGE III

CUTANEOUS T-CELL LYMPHOMA STAGE III was reported 23 times

CUTANEOUS T-CELL LYMPHOMA STAGE III is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PIMECROLIMUS 2 0.0011
1 MECHLORETHAMINE HYDROCHLORIDE 2 0.0009
2 ACITRETIN 3 0.0006
3 BARICITINIB 1 0.0003
4 BETAMETHASONE DIPROPIONATE 1 0.0001
5 NAPROXEN SODIUM 220MG 1 0.0001
6 ADALIMUMAB-FKJP 3 0.0001
7 ADALIMUMAB-AATY 3 0.0001
8 AZATHIOPRINE 5 0.0001
9 ADALIMUMAB-ADAZ 3 0.0001
10 MIRABEGRON 2 0.0001
11 CYCLOSPORINE 4 0.0000
12 OMALIZUMAB 3 0.0000
13 USTEKINUMAB 3 0.0000
14 DUPILUMAB 14 0.0000
15 MYCOPHENOLATE MOFETIL 3 0.0000
16 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 3 0.0000
17 SECUKINUMAB 3 0.0000
18 METHOTREXATE SODIUM 7 0.0000
19 APREMILAST 2 0.0000
20 ROSUVASTATIN 1 0.0000
21 BUPROPION HYDROCHLORIDE 1 0.0000
22 TACROLIMUS OINTMENT 0.1% 1 0.0000
23 TACROLIMUS EXTENDED-RELEASE CAPSULES 1 0.0000
24 PANTOPRAZOLE 2 0.0000
25 NAPROXEN SODIUM 1 0.0000
26 TACROLIMUS 1 0.0000
27 DIPHENHYDRAMINE HYDROCHLORIDE 1 0.0000
28 LOSARTAN 1 0.0000
29 ADALIMUMAB 3 0.0000
30 FOLIC ACID 1 0.0000
31 PREDNISONE 2 0.0000
32 METFORMIN ER 500 MG 1 0.0000
33 GABAPENTIN 1 0.0000
34 FUROSEMIDE 1 0.0000